First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Romee, R; Cooley, S; Berrien-Elliott, MM; Westervelt, P; Verneris, MR; Wagner, JE; Weisdorf, DJ; Blazar, BR; Ustun, C; Defor, TE; Vivek, S; Peck, L; DiPersio, JF; Cashen, AF; Kyllo, R; Musiek, A; Schaffer, A; Anadkat, MJ; Rosman, I; Miller, D; Egan,

Fehniger, TA (reprint author), Washington Univ, Sch Med, Dept Med, Div Oncol, 660 S Euclid Ave,Campus Box 8007, St Louis, MO 63110 USA.; Miller, JS (reprint author), Univ Minnesota, Ctr Canc, Div Hematol Oncol & Transplantat, MMC806,Harvard St & East Rive

BLOOD, 2018; 131 (23): 2515

Abstract

New therapies for patients with hematologic malignancies who relapse after allogeneic hematopoietic cell transplantation (allo-HCT) are needed. Interl......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索